Wellmos Global Healthcare Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2019
About Wellmos Global Healthcare Pharma
Wellmos Global Healthcare Pharma Private Limited (WGHPPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 November 2012 and has a history of 12 years and two months. Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Atul Jain and Parag Nandedkar serve as directors at the Company.
Company Details
-
Location
Indore, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51397MP2012PTC029575
-
Company No.
029575
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Nov 2012
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
What products or services does Wellmos Global Healthcare Pharma Private Limited offer?
Wellmos Global Healthcare Pharma Private Limited offers a wide range of products and services, including Bulk Bags & Sacks, Jumbo Bags, Woven Sacks, Polypropylene Woven Sacks, Protective Packing Materials, Protective Packaging.
Who are the key members and board of directors at Wellmos Global Healthcare Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parag Nandedkar
|
Director | 01-Feb-2015 | Current |
|
Atul Jain
|
Director | 23-Nov-2012 | Current |
Financial Performance of Wellmos Global Healthcare Pharma.
Wellmos Global Healthcare Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wellmos Global Healthcare Pharma?
In 2017, Wellmos Global Healthcare Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Packwise Packaging Solutions LlpParag Nandedkar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wellmos Global Healthcare Pharma?
Unlock and access historical data on people associated with Wellmos Global Healthcare Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wellmos Global Healthcare Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wellmos Global Healthcare Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
